Clinical Trial Update: The Effectiveness and Safety of Two Low-concentration Atropine Sulfate Eye Drops (0.01%/0.02%) for Delaying the Pediatric Myopia Progression [Phase 3]

View source ↗

Summary

This Phase 3 trial investigates whether two low-concentration atropine sulfate eye drops (0.01% and 0.02%) can slow pediatric myopia progression and assess safe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia
• Myopia Progression

Drugs mentioned

• Atropine sulfate eye drops (0.01%/0.02%) (atropine sulfate eye drops)

Snippet

Sponsor: Oupushifang Pharmaceutical Technology Co., Ltd. | Conditions: Myopia, Myopia Progression | Phase 3 | Status: RECRUITING